Axogen, Inc. Common Stock AXGN

$42.36 +2.47% at last close
Market Cap$2.25 billion
P/E Ratio
Div Yield
Volume1.76M
52-Week Range $9.21$45.83

Key Stats

Today's Range
$40.48 $42.60
50-Day Range
$30.42 $45.83
52-Week Range
$9.21 $45.83
Volume
1.76 million shs
Average Volume
887K shs
Market Cap
$2.25 billion
P/E Ratio
Dividend Yield

Valuation

P/E Ratio
Price / Book
9.20
Price / Sales
9.46

Short Interest

Short Interest
2.07%
Days to Cover
4.94

Financials (TTM)

Revenue
$238.10 million
Net Income
$-31,453,000
Net Margin
-13.21%
Return on Equity
-12.85%
Debt-to-Equity

About Axogen, Inc. Common Stock

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.

Sector
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Employees
622
Exchange
XNAS
Listed
1986-12-17

Related Stocks

Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.